Warfarin prevails for stroke prevention in atrial fibrillation-even in octogenarians

Lancet Neurology

Volumn 6, Issue 10, 2007, Pages 844-846

  Albers, Gregory W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; HUMANS; TREATMENT OUTCOME; WARFARIN;

EID: 34548640572     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70227-2     Document Type: Letter

References (6)

1. Mant J., Hobbs F., Fletcher K., et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial FibrillationTreatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370 (2007) 493-503
2. Aguilar M., Hart R., and Pearce L. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 3 (2007) CD006186.
3. Hart R., Pearce L., and Aguilar M. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007) 857-867
4. Gage B., Cardinalli A., Albers G., and Owens D. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 274 (1995) 1839-1845
5. Fuster V., Ryden L., Cannom D., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
6. Bungard T., Ghali W., Teo K., McAlister F., and Tsuyuki R. Why do patients with atrial fibrillation not receive warfarin?. Arch Intern Med 160 (2000) 41-46